Skip to content
DefDex

Federal award

BIOFIRE DIAGNOSTICS LLC

W81K0217F0062

Contract

Obligated and Ceiling

Obligated (net)
$1,112,639.84
Ceiling (potential value, not spending)
$1,177,588.96
Current value
$1,112,639.96
Gross positive obligations
$1,236,401.47

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BIOFIRE DIAGNOSTICS LLC · TBBNREFT3LD3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
COMPAGNIE MERIEUX ALLIANCE · PFPLR7Q9VGC8
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0217F0062
Parent vehicle (IDV PIID)
V797D30085
Award type code
C
Actions
13 · Sep 27, 2017 to Feb 14, 2023
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Feb 14, 2023FY2023P00012F−$39,100.67
—
Sep 28, 2020FY2020P00011B$0.00
—
Jan 8, 2020FY2020P00010D−$84,660.96
—
Nov 3, 2019FY2020P00009C$405,537.18
—
Jun 7, 2019FY2019P00008G$0.00
—
Nov 19, 2018FY2019P00007C$405,537.18
—
Aug 22, 2018FY2018P00006G$0.00
—
Jan 12, 2018FY2018P00005M$0.00
—
Dec 13, 2017FY2018P00004D$0.00
—
Dec 8, 2017FY2018P00003D$0.00
—
Dec 6, 2017FY2018P00002D$425,327.11
—
Nov 16, 2017FY2018P00001D$0.00
—
Sep 27, 2017FY20170—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.